STAT+: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment

"I do think it's a revolution," said Paul Oberstein of NYU Langone's Perlmutter Cancer Center.
Source
Stat News
Opens original article in a new tab



